Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis

References

• Sartorius N. A WHO method for the assessment of health-related quality of life (WHOQOL). Quality of life assessment: key issues in the 1990s, S Walker, R Rosser. Kluwer Academic, Dordrecht 1990; 201–207
   Google Scholar
• Gupta S, Kulhara P, Verma S K. Quality of life in schizophrenia and dysthymia. Acta Psychiatrica Scandinavica 1998; 97: 290–296
   PubMedGoogle Scholar
• Katschnig H. Schizophrenia and quality of life. Acta Psychiatrica Scandinavica 2000; 102(Suppl)33–37
   Google Scholar
• WHOQOL Group. The World Health Organisation WHOQOL-BREF quality of life assessment: position paper from the World Health Organisation. Social Science and Medicine 1998; 46: 1569–1585
   PubMed Web of Science ®Google Scholar
• Dogan S, Dogan O, Tel H, Coker F, Polatoz O, Dogan F B. Psychosocial approaches in outpatients with schizophrenia. Psychiatric Rehabilitation Journal 2004; 27: 279–282
   Google Scholar
• Herrman H, Hawthorne G, Thomas R. Quality of life assessment in people living with psychosis. Social Psychiatry and Psychiatric Epidemiology 2002; 37: 510–518
   PubMed Web of Science ®Google Scholar
• Becchi A, Rucci P, Placentino A, Neri G, de Girolamo G. Quality of life in patients with schizophrenia. Social Psychiatry and Psychiatric Epidemiology 2004; 39: 397–401
   PubMed Web of Science ®Google Scholar
• Pinikahana J, Happell B, Hope J, Keks N A. Quality of life in schizophrenia:a review ofthe literature from 1995–2000. International Journal of Mental Health Nursing 2002; 11: 103–111
   PubMedGoogle Scholar
• Ho B C, Nopoulos P, Flaum N, Arudt S, Andreasen N C. Two year outcome in first episode schizophrenia: predictive value of symptoms for quality of life. American Journal of Psychiatry 1998; 155: 1196–1201
   PubMed Web of Science ®Google Scholar
• Priebe S, Roeder-Wanner U U, Kaiser W. Quality of life in first-admitted schizophrenia patients: a follow-up study. Psychological Medicine 2000; 30: 225–230
   PubMedGoogle Scholar
• Addington J, Addington D. Neurocognitive and social functioning in schizophrenia. Schizophrenia Bulletin 1999; 25: 173–182
   PubMed Web of Science ®Google Scholar
• Fitzgerald D, Lucas S, Redoblado M A, et al. Cognitive functioning in young people with first episode psychosis: relationship to diagnosis and clinical characteristics. Australian and New Zealand Journal of Psychiatry 2004; 38: 501–510
   PubMed Web of Science ®Google Scholar
• Green M F, Kern R S, Braff D L, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?. Schizophrenia Bulletin 2000; 26: 119–136
   PubMed Web of Science ®Google Scholar
• Meltzer H Y, Thompson P A, Lee M A, Ranjan R. Neuropsychologic deficits in schizophrenia: relation to social functionand effect of antipsychotic drug treatment. Neuropsychopharmacology 1996; 14(Suppl)27–33
   Google Scholar
• Buchanan R W, Holstein C, Brier A. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Society of Biological Psychiatry 1994; 36: 717–725
   PubMed Web of Science ®Google Scholar
• Heslegrave R J, Awad A G, Voruganti L NP. The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia. Journal of Psychiatry and Neuroscience 1997; 22: 235–242
   PubMed Web of Science ®Google Scholar
• Aksaray G, Oflu S, Kaptanoglu C, Bal C. Neurocognitive deficits and quality of life in outpatients with schizophrenia. Progress in Neuro-psychopharmacology and Biological Psychiatry 2002; 26: 1217–1219
   PubMed Web of Science ®Google Scholar
• Addington J, Addington D. Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study. Schizophrenia Research 2000; 44: 47–56
   PubMed Web of Science ®Google Scholar
• Harris A, Brennan J, Anderson J, et al. The clinical profile of first episode psychosis in Western Sydney –scope and general findings of the Western Sydney First Episode Psychosis Project. Australian and New Zealand Journal of Psychiatry 2005; 39: 36–43
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders 4th edn. American Psychiatric Press, Washington, DC 1994
   Google Scholar
• Lambert T. Switching to risperdal. University of Melbourne, The Multimedia in Psychiatry Unit, Melbourne 1999
   Google Scholar
• Kay S R, Fizbein A, Opler L A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987; 13: 261–276
   PubMed Web of Science ®Google Scholar
• Addington J, Addington D. Cognitive functioning in first episode schizophrenia. Journal of Psychiatry and Neuroscience 2002; 27: 188–192
   PubMed Web of Science ®Google Scholar
• Wechsler D. Wechsler Abbreviated Scale of Intelligence. The Psychological Corporation, San Antonio, TX 1999
   Google Scholar
• Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms and commentary 2nd edn. Oxford University Press, New York, NY 1998
   Google Scholar
• Conners C K. Multi-health Systems Staff. Conners' Continuous Performance Test. MHS, Toronto 1995
   Google Scholar
• Delis D C, Kaplan E, Kramer J H. Delis–Kaplan Executive Functioning System. The Psychological Corporation, San Antonio, TX 2001
   Google Scholar
• Hawthorne G, Richardson J, Day N, McNeil H. Validation of the WHOQOL-BREF. Centre for Health Program Evaluation, Melbourne 2000
   Google Scholar
• Statistical Package for the Social Sciences (SPSS). SPSS for Windows (version 11.0). SPSS Inc, Chicago 2001
   Google Scholar
• Laroi F, Fannemel M, Ronnebberg U, et al. Unawareness of illness in chronic schizophrenia and its relationship to structural brain measures and neuropsychological tests. Psychiatry Research 2000; 100: 49–58
   PubMed Web of Science ®Google Scholar
• Tollefson G D, Andersen S W. Should we consider mood disturbances in schizophrenia as an important determinant of quality of life. Journal of Clinical Psychiatry 1999; 60: 23–29
   PubMedGoogle Scholar
• Huppert J D, Weiss K A, Lim R, Pratt S, Smith T E. Quality of life in schizophrenia: contributions of anxiety and depression. Schizophrenia Research 2001; 51: 171–180
   PubMed Web of Science ®Google Scholar
• Heinrichs D W, Hanlon T E, Carpenter W T. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin 1984; 10: 388–398
   PubMed Web of Science ®Google Scholar
• Bow-Thomas C C, Velligan D I, Miller A L, Olsen J. Predicting quality of life from symptomatology at exacerbation and stabilisation. Psychiatry Research 1999; 86: 131–142
   PubMed Web of Science ®Google Scholar
• Norman R MG, Malla A K, McLean T, et al. The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the quality of life scale. Acta Psychiatrica Scandinavica 2000; 102: 303–309
   PubMed Web of Science ®Google Scholar